The M&A landscape is buzzing with a fierce bidding war for Baton Rouge-based Amedisys, a leading home health and hospice care provider. Initially, Illinois-based Option Care Health proposed an all-stock offer of $3.6 billion. However, Optum Health Inc., a subsidiary of UnitedHealth Group, countered with an unsolicited all-cash offer of $100 per share, valuing Amedisys at $3.75 billion.
Amedisys CEO, Richard Ashworth, believes the deal with Option Care Health will deliver significant value to stockholders. However, the board has entered into a confidentiality agreement with Optum Health, indicating potential shifts. This comes amidst a backdrop of declining share prices for Amedisys, partially attributed to Medicare lowering reimbursement rates. As the bidding war intensifies, it's a reminder of the dynamic nature of M&A activity and the strategic value companies see in the home health care sector.
Chaffe & Associates, Inc. Gay Le Breton
#MergersAndAcquisitions #HealthcareIndustry #Amedisys #OptionCareHealth #OptumHealth
https://lnkd.in/gu7yY7Pa